Molecular modelling studies and in vitro enzymatic assays identified A 4-(nitrobenzyl)guanidine derivative as inhibitor of SARS-CoV-2 Mpro
Article in Scientific Reports (April 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in Scientific Reports (April 2024)
Article in ACS Omega (March 2024)
Article in Frontiers in Pharmacology (August 2022)